~~<i id='D03FA222EB'><strike id='D03FA222EB'><tt id='D03FA222EB'><pre id='D03FA222EB'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

leisure time

author：entertainment 2025-09-28 02:28:36 - browse：677

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： KalVista pill reduced swelling 'attacks' caused by genetic disease

leisure time

hotspot

Wikipedia

focus

explore

AdobeDoctorsarefullofadvice:Eathealthy.Exercise.Don’tmissyourmedications.Don’tgetthatunnecessarytest

WSS

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

VC firm General Catalyst wants to buy a health system

Why Charlie Gard's case is so disturbing to Americans

Sana to lay off nearly a third of staff, de

A Q&A with the global head of Boehringer Ingelheim's innovation unit

The dental labor crisis is a moment of opportunity

entertainment

leisure time

leisure time

After affirmative action ruling, medical educators look to 'holistic review'

Senators start work on Medicare physician payment reform

What does generative AI mean for health care? We asked experts

AI can decode, harness the power of the humane immune system

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Key House Republican on health care plans exit from Congress

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Bill would stop addiction treatment from triggering child abuse inquiry

leisure time

When women are denied an abortion, their children fare worse than peers

Chan Zuckerberg Biohub Chicago to focus on inflammation

Biden report: The neurospychology of memory and aging

For Medicare Advantage, Democrats want stronger protections around AI

Analysis of telehealth claims data suggest service duplication

3 questions for the future of Biden's cancer moonshot

hotspot

Wikipedia

focus

explore